Home > Surveillance and prevention of hepatitis B and C in Europe.

European Centre for Disease Prevention and Control. (2010) Surveillance and prevention of hepatitis B and C in Europe. Stockholm: ECDC.

[img]
Preview
PDF (ECDC hepatitis B and C in Europe) - Published Version
3MB

ECDC releases two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatitis B and C in Europe’ and ‘Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies’.

Hepatitis surveillance is implemented in all Member States but varies considerably across countries. Universal vaccination programmes for HBV are implemented in 22 countries and seven countries have established targeted vaccination programmes.

The majority of the countries have implemented screenings for HBV in pregnant women; only four countries do not have such a programme. Half of the countries conduct screening programmes for hepatitis C, primarily for injecting drug users and prison inmates. Prevalence data on HBV and HCV remain scarce in many countries, both for the general population and groups-at-risk.


Date:2010
Pages:143 p.
Publisher:ECDC
Corporate Creators:European Centre for Disease Prevention and Control
Place of Publication:Stockholm
ISBN:978-92-9193-216-0
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
G Health and disease > Disorder by cause > Communicable disease > Hepatitis B
VA Geographic area > Europe
J Health care, prevention and rehabilitation > Health-related prevention > Health information and education > Communicable disease control

Repository Staff Only: item control page